Episode
How Drug Repurposing Unlocks New Uses for Existing Medicines: Every Cure’s David Fajgenbaum
- Podcast
- from Dreamers to Disruptors
- Published
- Dec 15, 2025
- Duration seconds
- 2913
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/from-dreamers-to-disruptors/2392871
Actions
POST https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/how-drug-repurposing-unlocks-new-uses-for-existing-medicines-every-cure-s-david-fajgenbaum/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/how-drug-repurposing-unlocks-new-uses-for-existing-medicines-every-cure-s-david-fajgenbaum.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
David Fajgenbaum’s relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Castleman disease and running out of treatment options, David used his research skills to identify an existing drug that saved his life. Join David and Medidata CEO Anthony Costello to explore the origins of Every Cure—and how David’s experience became the seed for a nonprofit that uncovers life-changing uses for treatments already approved for other conditions. Discover Every Cure’s innovative approaches to data, the scope of unmet needs across healthcare, and how pharmaceutical companies can contribute to a future where we unlock the full potential of treatments for all. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow David: LinkedIn